JPH0548204B2 - - Google Patents
Info
- Publication number
- JPH0548204B2 JPH0548204B2 JP63167278A JP16727888A JPH0548204B2 JP H0548204 B2 JPH0548204 B2 JP H0548204B2 JP 63167278 A JP63167278 A JP 63167278A JP 16727888 A JP16727888 A JP 16727888A JP H0548204 B2 JPH0548204 B2 JP H0548204B2
- Authority
- JP
- Japan
- Prior art keywords
- plaster
- parts
- gypsum
- powder
- antibacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000011505 plaster Substances 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 35
- 239000010440 gypsum Substances 0.000 claims description 31
- 229910052602 gypsum Inorganic materials 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 30
- 229960001950 benzethonium chloride Drugs 0.000 claims description 16
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 16
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 14
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 14
- 239000003242 anti bacterial agent Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000004898 kneading Methods 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- -1 alginate ester Chemical class 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229960003872 benzethonium Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Landscapes
- Dental Preparations (AREA)
Description
(産業上の利用分野)
本発明は、歯科医療において歯型模型の作成に
用いられる石膏材に関する。
(従来技術とその課題)
一般に、歯科医療における歯型の形成は、アル
ギン酸塩や寒天を主剤とした印象材を患者の歯か
ら歯茎にかけて印圧して硬化(ゲル化)させて凹
型の印象を採得し、歯科技工士がこの採得印象材
の凹型内に石膏を注入し、硬化した石膏型を取り
出して技工を加えて歯型模型とする手順で行われ
る。
ここで、上記印象材は、使用に際して患者の口
腔内に直接に接触するため、唾液や血液等の体液
ならびに歯垢や食物残渣等の汚垢が付着し、必然
的に患者の保有する細菌やウイルスに汚染され
る。そして、この汚染された印象材より型取りさ
れる石膏型へも当然に汚染が移行することにな
る。
従つて、歯科医療従事者の中でも特に歯型作成
に携わる歯科技工士にあつては、汚染された石膏
型を取り扱う上に、技工に際してカーバイトバー
等の鋭利な工具を用いるために手指等に傷を受け
たり、石膏型の研磨加工によつて生じる微粉を吸
引する機会が多々あり、様々な感染の危険が大き
く、特に近年ではB型肝炎やエイズ(AIDS)の
感染が懸念されている。
(課題を解決するための手段)
本発明は、上述の情況に鑑みて、歯型模型の作
成用としてそれ自体が除菌機能を具備するという
画期的な石膏材を提供し、もつて歯科技工におけ
る様々な感染を危険性を排除することを目的とし
ている。
すなわち、上記目的を達成するために、本発明
の歯型模型用石膏材は、石膏粉末100重量部に対
して塩化ベンゼトニウムまたは/および塩化ベン
ザルコニウムが0.025〜1.0重量部配合されてなる
構成を採用したものである。
(発明の細部構成と作用)
本発明において石膏中に配合される塩化ベンゼ
トニウムは、下記構造式;
で表されるものであり、また塩化ベンザルコニウ
ムは下記構造式;
〔R:C8H17〜C18H37〕
で表されるものであり、共に抗菌スペクトルが広
く、かつHBs抗原(B型肝炎表面抗原)の不活
性作用を有する抗菌剤として既知であるが、特に
歯型模型用の石膏に対して非常に優れた適性を有
している。
すなわち、石膏配合用の抗菌剤としては、これ
を含む石膏粉末が使用前に固化するのを避ける点
から、常温下では固形状であつてかつ遊離水がで
きるだけ少なく、また型形成に際して石膏粉末を
水に解いたときにその水中に直ちに溶解して抗菌
作用を発揮するものでなければならず、無論のこ
と化合物として安定性がよく作用の持続性に優れ
ることも要求される。しかして、塩化ベンゼトニ
ウムおよび塩化ベンザルコニウムは共に、常温下
で粉末状のものとして得られ、かつ水易溶性であ
つて低濃度でも高い抗菌作用(例えば、HBs抗
原不活化最小有効濃度は、塩化ベンゼトニウムで
0.01%、塩化ベンザルコニウムで0.04%)を示
し、また安定性に優れた化合物であるため、前記
の石膏配合用としての必要特性を全て満足する。
これに対し、抗菌スペクトルが広くかつHBs
抗原不活性化作用を示す抗菌剤として他に、次亜
塩素酸ナトリウムや高度サラシ粉の如き塩素系抗
菌剤、ココイルアルギン酸エステル(CAE…Na
−Cocoyl−L−arginine ethylester−DL−
pyroglntamic acid salt)の如きカチオン界面活
性剤系抗菌剤、イルガサンDP−300(スイス国チ
バガイギー社の商品名、2・4・4′−トリクロロ
−2′−ヒドロキシ−ジフエニルエーテル)等が知
られるが、これらはいずれも石膏配合用として不
適である。すなわち、塩素系抗菌剤は安定性に劣
り抗菌作用の持続性に難があると共に分解生成し
たCl2ガスによる毒性や腐蝕の問題もあり、また
CAEおよびイルガサンDP−300は水に難溶性で
あることから、抗菌作用が発現しにくいという欠
点がある。
本発明の歯型模型用石膏材における塩化ベンゼ
トニウムまたは/および塩化ベンザルコニウムの
配合量は、石膏粉末100重量部に対して0.025〜
1.0重量部の範囲とすべきである。すなわち、こ
の配合量が0.025重量部より少ない場合は、印象
材より移行した雑菌等に対する抗菌作用が充十分
であり、逆に1.0重量部より多くなつても、抗菌
効果的にはほぼ飽和に達しかつ高価でもあること
から不経済となる上に石膏特性に悪影響を及ぼす
惧れもある。なお、塩化ベンゼトニウムと塩化ベ
ンザルコニウムとは併用しても差し支えない。
この塩化ベンゼトニウムまたは/および塩化ベ
ンザルコニウムを石膏粉末中に配合する手段とし
ては、粉末形態で石膏粉末に混合する方法のほか
高濃度エチルアルコール等の少量(例えばエチル
アルコールでは1〜3容量倍程度)の揮発性溶剤
に溶解した溶液として石膏粉末に噴霧あるいは直
接添加し、溶剤の揮散後に石膏粉末を撹拌混合す
る方法も採用できる。なお、これら配合において
は塩化ベンゼトニウムまたは/および塩化ベンザ
ルコニウムの均一分散を図るために、これをまず
少量の石膏粉末と混合した後、この混合物に何回
かに分けて石膏粉末を追加して撹拌混合し、最終
的に所要の塩化ベンゼトニウムまたは/および塩
化ベンザルコニウム配合量の石膏材とするのがよ
い。また上記溶液として添加した際に凝集が生じ
た場合は粉砕機を用いて粉砕すればよい。
かくして塩化ベンゼトニウムまたは/および塩
化ベンザルコニウムを配合した歯型模型用石膏材
は、硬化性、硬化時の体積変化、硬化物の強度等
の特性において従来の抗菌剤を含まない歯型模型
用石膏と同等である。その使用に際しては、従来
のものと同様に、水と練和し、この練和物を印象
採得後の硬化した印象材の凹型に注入し、硬化後
に離型して所要の技工を施せばよく、型取り精度
および強度面で全く問題のない歯型模型を得るこ
とができる。
(実施例)
以下、本発明の実施例につき性能比較試験を含
めて説明する。なお、以下において部とあるは重
量部を意味する。
実施例 1
石膏粉末5部の入つた混合撹拌機中に塩化ベン
ゼトニウム粉末0.1部を投入して混合撹拌した後、
石膏粉末15部を追加して混合撹拌し、更に30部お
よび50部の石膏粉末を順次追加して同様に混合撹
拌し、石膏粉末100部に対して塩化ベンゼトニウ
ム0.1部が均一に配合された抗菌剤入り石膏材を
得た。
一方、印象材用寒天と印象材用アルギン酸塩と
組合せた印象材を用い、50才男性より下顎部の歯
全体にわたる印象を滅菌したトレイに採得し、こ
の採得印象材を金属板にてほぼ正中線で2分割し
た。そして、この印象材の右半体には水で練和し
た通常の模型用石膏を注入し、左半体には水で練
和した上記の抗菌剤入り石膏材を注入し、それぞ
れウエツト槽内で室温硬化させた後、これらを取
り出して石膏模型を得た。次に右半体石膏模型の
歯番号を7、6、5、4、3および左半体石膏模
型の歯番号を3、4、5、6、7の各歯顎部を技
工用カーバイトバーで削つて粉塊を採取し、それ
ぞれ標準寒天培地シヤーレに植種した。そして、
植種した各培地を36±1℃の恒温器内で放置し、
歯の繁殖の有無を調べたところ、表1の結果が得
られた。なお、表中の記号(+)は菌繁殖であ
り、記号(−)は菌繁殖なし、をそれぞれ意味す
る。
(Industrial Application Field) The present invention relates to a plaster material used for creating dental models in dental care. (Prior art and its problems) In general, tooth molds are formed in dentistry by applying pressure from the patient's teeth to the gums with an impression material containing alginate or agar as a main ingredient, and hardening (gelling) it to form a concave impression. Then, a dental technician injects plaster into the concave mold of this impression material, takes out the hardened plaster mold, and adds techniques to create a dental model. Here, since the above-mentioned impression material comes into direct contact with the patient's oral cavity during use, body fluids such as saliva and blood as well as stains such as dental plaque and food residue adhere to the impression material, which inevitably causes bacteria and bacteria carried by the patient to adhere to the impression material. become contaminated with viruses. Naturally, the contamination also transfers to the plaster mold that is molded from this contaminated impression material. Therefore, among dental healthcare workers, especially dental technicians who are involved in making dental molds, it is important to avoid touching your hands and fingers when handling contaminated plaster molds and using sharp tools such as carbide burs during the technique. There are many opportunities to get scratched or inhale fine powder generated by polishing plaster molds, and there is a great risk of various infections, and in recent years there has been a particular concern about hepatitis B and AIDS infections. (Means for Solving the Problems) In view of the above-mentioned circumstances, the present invention provides an innovative plaster material that itself has a sterilizing function for use in creating dental models, and provides dental treatment. The purpose is to eliminate the risk of various infections in technicians. That is, in order to achieve the above object, the plaster material for dental models of the present invention has a composition in which 0.025 to 1.0 parts by weight of benzethonium chloride and/or benzalkonium chloride are blended with 100 parts by weight of gypsum powder. This is what was adopted. (Detailed structure and operation of the invention) Benzethonium chloride mixed into plaster in the present invention has the following structural formula; Benzalkonium chloride is represented by the following structural formula; [R: C 8 H 17 - C 18 H 37 ], both of which are known as antibacterial agents that have a broad antibacterial spectrum and have the effect of inactivating HBs antigen (hepatitis B surface antigen). It has excellent suitability, especially for plaster for dental models. In other words, in order to prevent the gypsum powder containing it from solidifying before use, antibacterial agents for use in plaster formulations should be solid at room temperature and contain as little free water as possible, and should be used when forming gypsum powder during mold formation. When dissolved in water, it must immediately dissolve in the water and exhibit antibacterial action, and of course it is also required that the compound be stable and have excellent sustainability of action. Both benzethonium chloride and benzalkonium chloride are obtained as powders at room temperature, are easily water-soluble, and have high antibacterial activity even at low concentrations (for example, the minimum effective concentration for inactivating HBs antigen is with benzethonium
0.01% and 0.04% for benzalkonium chloride), and because it is a compound with excellent stability, it satisfies all the necessary properties for use in plaster formulations. In contrast, HBs has a broad antibacterial spectrum and
Other antibacterial agents that exhibit antigen inactivation effects include chlorine-based antibacterial agents such as sodium hypochlorite and high-grade salashi powder, and cocoyl alginate ester (CAE...N a
−Cocoyl−L−arginine etylester−DL−
Cationic surfactant-based antibacterial agents such as pyroglntamic acid salt) and Irgasan DP-300 (trade name of Ciba Geigy, Switzerland, 2,4,4'-trichloro-2'-hydroxy-diphenyl ether) are known. , these are all unsuitable for use in plaster formulations. In other words, chlorine-based antibacterial agents have poor stability and difficulty in maintaining antibacterial action, and there are also problems with toxicity and corrosion due to the Cl2 gas produced by decomposition.
Since CAE and Irgasan DP-300 are poorly soluble in water, they have the disadvantage of being difficult to develop antibacterial effects. The blending amount of benzethonium chloride and/or benzalkonium chloride in the plaster material for dental models of the present invention is 0.025 to 100 parts by weight of plaster powder.
It should be in the range of 1.0 part by weight. In other words, when this amount is less than 0.025 parts by weight, the antibacterial effect against bacteria transferred from the impression material is sufficient, and even when it is more than 1.0 parts by weight, the antibacterial effect is almost saturated. Since it is also expensive, it is uneconomical and may have a negative effect on the properties of gypsum. Note that benzethonium chloride and benzalkonium chloride may be used together. The benzethonium chloride and/or benzalkonium chloride can be blended into the gypsum powder by mixing it with the gypsum powder in powder form, or by adding a small amount of highly concentrated ethyl alcohol (for example, 1 to 3 times the volume of ethyl alcohol). ) may be sprayed or directly added to gypsum powder as a solution dissolved in a volatile solvent, and the gypsum powder may be stirred and mixed after the solvent has volatilized. In addition, in these formulations, in order to uniformly disperse benzethonium chloride and/or benzalkonium chloride, this is first mixed with a small amount of gypsum powder, and then gypsum powder is added to this mixture in several portions. It is preferable to stir and mix the ingredients to finally form a plaster material containing the required amount of benzethonium chloride and/or benzalkonium chloride. Further, if agglomeration occurs when the above-mentioned solution is added, it may be pulverized using a pulverizer. Thus, the plaster material for dental models containing benzethonium chloride and/or benzalkonium chloride is superior to conventional plaster materials for dental models that do not contain antibacterial agents in terms of properties such as hardenability, volume change during curing, and strength of the cured product. is equivalent to To use it, as with conventional products, mix it with water, inject this mix into the concave mold of the hardened impression material after taking the impression, and after hardening, release the mold and perform the required technique. It is possible to obtain a tooth model with no problems in terms of molding accuracy and strength. (Example) Examples of the present invention will be described below, including performance comparison tests. In addition, in the following, parts mean parts by weight. Example 1 After putting 0.1 part of benzethonium chloride powder into a mixer containing 5 parts of gypsum powder and stirring,
Add 15 parts of gypsum powder and mix and stir, then add 30 parts and 50 parts of gypsum powder one by one and mix and stir in the same way to create an antibacterial mixture in which 0.1 part of benzethonium chloride is evenly mixed with 100 parts of gypsum powder. A plaster material containing the agent was obtained. On the other hand, an impression covering the entire lower teeth of a 50-year-old man was taken on a sterilized tray using an impression material that was a combination of agar for impression materials and alginate for impression materials, and this impression material was then placed on a metal plate. It was divided into two approximately along the midline. Then, regular modeling plaster mixed with water is injected into the right half of this impression material, and the above antibacterial agent-containing plaster mixed with water is injected into the left half, and each is placed in a wet tank. After curing at room temperature, they were taken out to obtain a plaster model. Next, set the tooth numbers 7, 6, 5, 4, 3 on the right half plaster model and the tooth numbers 3, 4, 5, 6, 7 on the left half plaster model with a carbide bar for the technician. The powder was collected by scraping and inoculated into standard agar medium plates. and,
Leave each inoculated medium in a thermostat at 36 ± 1°C,
When examining the presence or absence of tooth reproduction, the results shown in Table 1 were obtained. In addition, the symbol (+) in the table means bacterial propagation, and the symbol (-) means no bacterial propagation.
【表】
実施例 2
塩化ベンゼトニウムに代えて塩化ベンザルコニ
ウム0.1部を使用した以外は実施例1の同様にし
て抗菌剤入り石膏材を得た。そして、この石膏材
と通常の模型用石膏とを用い、実施例1と同様に
して40才男性より採得した印象材を対象として、
実施例1に準じて石膏模型の作製と植種による菌
繁殖試験を行つたところ、下記表2の結果が得ら
れた。[Table] Example 2 An antibacterial agent-containing gypsum material was obtained in the same manner as in Example 1, except that 0.1 part of benzalkonium chloride was used in place of benzethonium chloride. Then, using this plaster material and ordinary plaster for modeling, an impression material obtained from a 40-year-old man in the same manner as in Example 1 was used.
According to Example 1, a plaster model was prepared and a bacterial propagation test by seeding was conducted, and the results shown in Table 2 below were obtained.
【表】
実施例 3
実施例1、2と同様手段により、石膏粉末100
部に対して塩化ベンゼトニウム粉末および塩化ベ
ンザルコニウム粉末をそれぞれ0.0125部、0.025
部、0.05部、0.1部配合した抗菌剤入り石膏材を
作製した。そして、各石膏材と抗菌剤無配合の石
膏粉末につき、その100gに対し、台所流し台の
ゴミ受け部より採取した菌数約5×103個/mlの
雑菌水(標準寒天培地36℃、48hr後に生菌数測
定)1mlを添加した練和用水24ml、ならびに同雑
菌水10mlを添加した練和用水24mlを用いて、それ
ぞれ1分間練和し、練和直後()と練和後10分
経過時点()で2〜3gの練和石膏を2検体ず
つシヤーレに取り、各シヤーレに直ちに約50℃の
標準寒天培地20mlを注入し、培地が固化した後、
36±1℃の恒温器中で放置し、石膏近傍および培
地の菌繁殖の有無を放置日数ごとに調べたとこ
ろ、表3−1〜3−4で表す結果が得られた。な
お、表中の記号(+)は菌繁殖であり、(−)は
菌繁殖なし、をそれぞれ意味する。[Table] Example 3 Using the same method as in Examples 1 and 2, 100% gypsum powder was prepared.
0.0125 parts and 0.025 parts of benzethonium chloride powder and benzalkonium chloride powder, respectively.
Gypsum materials containing antibacterial agents were prepared containing 0.05 parts, 0.05 parts, and 0.1 parts. For each gypsum material and gypsum powder containing no antibacterial agent, for each 100g of gypsum powder, bacteria water with a number of bacteria of approximately 5 x 10 3 /ml collected from the garbage receptacle of the kitchen sink (standard agar medium 36℃, 48 hours Using 24 ml of kneading water to which 1 ml of viable bacteria was added (after measuring the number of viable bacteria) and 24 ml of kneading water to which 10 ml of contaminant water was added, each was kneaded for 1 minute, and immediately after kneading () and 10 minutes after kneading. At time point (), take two samples of 2 to 3 g of kneaded gypsum into a shear dish, and immediately pour 20 ml of standard agar medium at about 50°C into each shear dish, and after the medium has solidified,
The samples were left in a thermostat at 36±1°C, and the presence or absence of bacterial growth in the vicinity of the plaster and in the culture medium was examined for each number of days, and the results shown in Tables 3-1 to 3-4 were obtained. In addition, the symbol (+) in the table means bacterial propagation, and (-) means no bacterial propagation.
【表】【table】
【表】【table】
【表】【table】
【表】
表3−1〜3−4の結果から、塩化ベンゼトニ
ウムおよび塩化ベンザルコニウムは、共に石膏粉
末100部に対して0.025部以上の配合量で充分な抗
菌効果が得られることが明らかである。
実施例 4
塩化ベンゼトニウム0.1部を3倍容量の99.5%
のエチルアルコールに溶解し、この溶液を40℃の
石膏粉末6部に撹拌下で粉霧添加し、エチルアル
コールが揮散した後に石膏粉末14部を追加して混
合撹拌し、更に30部および50部の石膏粉末を順次
追加して混合撹拌し、抗菌剤入り石膏材A得た。
この石膏材Aと実施例1で得た抗菌剤入り石膏材
Bにつき、それぞれ混水量24ml/100gとして、
石膏特性をJIS−T6605に準じ測定したところ、
表4の結果が得られた。[Table] From the results in Tables 3-1 to 3-4, it is clear that sufficient antibacterial effects can be obtained with benzethonium chloride and benzalkonium chloride in amounts of 0.025 parts or more per 100 parts of gypsum powder. be. Example 4 0.1 part of benzethonium chloride 99.5% of 3 times the volume
This solution was added to 6 parts of gypsum powder at 40℃ under stirring, and after the ethyl alcohol had evaporated, 14 parts of gypsum powder was added and mixed with stirring, followed by 30 parts and 50 parts. gypsum powder was added in sequence and mixed and stirred to obtain antibacterial agent-containing gypsum material A.
For this gypsum material A and the antibacterial agent-containing gypsum material B obtained in Example 1, the mixed water amount was 24 ml/100 g, respectively.
When the gypsum properties were measured according to JIS-T6605,
The results shown in Table 4 were obtained.
【表】
表4の結果から、本発明の石膏材は、硬化性、
硬化時の体積変化、強度等のいずれにおいても支
障がなく、歯型模型用石膏として充分な適性を具
備することが明らかである。
(発明特有の効果)
本発明の歯型模型用石膏材によれば、この石膏
材自体が優れた抗菌作用を有するため、歯型模型
作成において患者の口腔内の体液や汚垢に汚染さ
れた印象材から石膏の歯型模型への菌やウイルス
の移行汚染が防止され、もつて歯科技工における
様々な感染の危険性が回避される。また、この石
膏材は、硬化性、硬化後の体積変化、強度等の石
膏特性において歯型模型用石膏としての充分な適
性を有している。[Table] From the results in Table 4, the gypsum material of the present invention has hardening properties,
It is clear that there is no problem in volume change during curing, strength, etc., and that the plaster has sufficient suitability as a plaster for dental models. (Effects Unique to the Invention) According to the plaster material for dental models of the present invention, since the plaster material itself has an excellent antibacterial effect, it is possible to avoid contamination with bodily fluids and dirt in the patient's oral cavity during the creation of dental models. Transfer contamination of bacteria and viruses from the impression material to the plaster tooth model is prevented, thereby avoiding the risk of various infections in dental techniques. Furthermore, this plaster material has sufficient suitability as a plaster for dental models in terms of plaster properties such as hardenability, volume change after hardening, and strength.
Claims (1)
ウムまたは/および塩化ベンザルコニウムが
0.025〜1.0重量部配合されてなる歯型模型用石膏
材。1 Benzethonium chloride or/and benzalkonium chloride per 100 parts by weight of gypsum powder
A plaster material for dental models containing 0.025 to 1.0 parts by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63167278A JPH0217110A (en) | 1988-07-05 | 1988-07-05 | Gypsum material for tooth form model |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63167278A JPH0217110A (en) | 1988-07-05 | 1988-07-05 | Gypsum material for tooth form model |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0217110A JPH0217110A (en) | 1990-01-22 |
| JPH0548204B2 true JPH0548204B2 (en) | 1993-07-20 |
Family
ID=15846781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63167278A Granted JPH0217110A (en) | 1988-07-05 | 1988-07-05 | Gypsum material for tooth form model |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0217110A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2515161B2 (en) * | 1988-11-24 | 1996-07-10 | 株式会社ジーシーデンタルプロダクツ | Dental gypsum composition |
| JP2776572B2 (en) * | 1989-07-17 | 1998-07-16 | バブコツク日立株式会社 | Pulverized coal burner |
| JP3773990B2 (en) * | 1996-07-23 | 2006-05-10 | 株式会社三菱化学ヤトロン | Dental plaster composition |
| KR100785232B1 (en) * | 2006-06-15 | 2007-12-11 | 남두석 | Dental antibacterial gypsum composition and its manufacturing method |
-
1988
- 1988-07-05 JP JP63167278A patent/JPH0217110A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0217110A (en) | 1990-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Punj et al. | Dental impression materials and techniques | |
| EP0265776B1 (en) | Dental impression material | |
| Al-Jabrah et al. | Antimicrobial effect of 4 disinfectants on alginate, polyether, and polyvinyl siloxane impression materials. | |
| JP5065369B2 (en) | Pathogen reduction and sterilization methods for impression materials and their components | |
| JPH0725649B2 (en) | Disinfectant-containing alginate impression material | |
| JPH0217523B2 (en) | ||
| Allard et al. | Endodontic treatment of experimentally induced apical periodontitis in dogs | |
| Breault et al. | Die stone disinfection: incorporation of sodium hypochlorite | |
| Dapello-Zevallos et al. | Disinfection of dental impression materials and its effects on dimensional changes: a literature review | |
| Ahila et al. | Effect of disinfection on gypsum casts retrieved from addition and condensation silicone impressions disinfected by immersion and spray methods | |
| JPH0548204B2 (en) | ||
| Fernandes et al. | A comparative study of the effect of different disinfectant solutions on the compressive strength of type III gypsum | |
| US4242239A (en) | Bondable agar dental impression material | |
| AU628391B2 (en) | Process for disinfecting medical casting materials | |
| JPS63115806A (en) | Production of dental zinc oxide eugenol cement composition | |
| JPH02152916A (en) | Bacteria-removing detergent for dental impression material | |
| JP2515161B2 (en) | Dental gypsum composition | |
| JP5439642B2 (en) | Bactericidal root canal sealer and preparation kit | |
| Ravivarman et al. | Comparative Evaluation of pH and In Vitro Cytotoxicity of Zinc Oxide–Ozonated Eugenol and Conventional Zinc Oxide Eugenol as Endodontic Sealers | |
| JPH01107753A (en) | Impression disinfection | |
| Mathew et al. | The Effect of disinfectants on the properties of commercially available alginate impression material | |
| CN1030697A (en) | Autodisinfecting impression material | |
| Ralph et al. | The effects of disinfectants on the dimensional stability of alginate impression materials | |
| H. Alfahdawi et al. | Evaluate (0.2% CHX) disinfection solution effects Incorporation on the setting time, setting expansion and compressive strength of Dental Stone | |
| JP2851664B2 (en) | A composition for cleaning and disinfecting dental trays that is excellent in preventing discoloration and antibacterial action of the tray |